[
    {
        "activityscore": {
            "G6PD": "n/a"
        },
        "allelestatus": {},
        "classification": "No recommendation.",
        "comments": "n/a",
        "drug": {
            "name": "rasburicase"
        },
        "drugid": "RxNorm:283821",
        "drugrecommendation": "No recommendation.",
        "guideline": {
            "name": "G6PD and Rasburicase"
        },
        "guidelineid": 100420,
        "id": 1352355,
        "implications": {
            "G6PD": "n/a"
        },
        "lookupkey": {
            "G6PD": "Indeterminate"
        },
        "phenotypes": {
            "G6PD": "Indeterminate"
        },
        "population": "general",
        "version": 1
    },
    {
        "activityscore": {
            "G6PD": "n/a"
        },
        "allelestatus": {},
        "classification": "Strong",
        "comments": "Allopurinol is associated with severe cutaneous reactions in the rare carriers of the HLA-B*58:01 allele.",
        "drug": {
            "name": "rasburicase"
        },
        "drugid": "RxNorm:283821",
        "drugrecommendation": "Rasburicase is contraindicated; alternatives include allopurinol.",
        "guideline": {
            "name": "G6PD and Rasburicase"
        },
        "guidelineid": 100420,
        "id": 1352354,
        "implications": {
            "G6PD": "At risk of acute hemolytic anemia"
        },
        "lookupkey": {
            "G6PD": "Deficient"
        },
        "phenotypes": {
            "G6PD": "Deficient"
        },
        "population": "general",
        "version": 1
    },
    {
        "activityscore": {
            "G6PD": "n/a"
        },
        "allelestatus": {},
        "classification": "Moderate",
        "comments": "Allopurinol is associated with severe cutaneous reactions in the rare carriers of the HLA-B*58:01 allele.",
        "drug": {
            "name": "rasburicase"
        },
        "drugid": "RxNorm:283821",
        "drugrecommendation": "To ascertain that G6PD status is normal, enzyme activity must be measured; alternatives include allopurinol.",
        "guideline": {
            "name": "G6PD and Rasburicase"
        },
        "guidelineid": 100420,
        "id": 1352353,
        "implications": {
            "G6PD": "Unknown risk of hemolytic anemia"
        },
        "lookupkey": {
            "G6PD": "Variable"
        },
        "phenotypes": {
            "G6PD": "Variable"
        },
        "population": "general",
        "version": 1
    },
    {
        "activityscore": {
            "G6PD": "n/a"
        },
        "allelestatus": {},
        "classification": "Strong",
        "comments": "A negative or inconclusive genetic test cannot be assumed to indicate normal G6PD phenotype; an enzyme actiity test is needed to assign G6PD phenotype in such cases.",
        "drug": {
            "name": "rasburicase"
        },
        "drugid": "RxNorm:283821",
        "drugrecommendation": "No reason to withhold rasburicase based on G6PD status.",
        "guideline": {
            "name": "G6PD and Rasburicase"
        },
        "guidelineid": 100420,
        "id": 1352352,
        "implications": {
            "G6PD": "Low or reduced risk of hemolytic anemia"
        },
        "lookupkey": {
            "G6PD": "Normal"
        },
        "phenotypes": {
            "G6PD": "Normal"
        },
        "population": "general",
        "version": 1
    }
]